FECAL CALPROTECTIN AND DRUG LEVELS AT WEEK 14 PREDICT LONG-TERM RESPONSE OF VEDOLIZUMAB IN PAEDIATRIC INFLAMMATORY BOWEL DISEASES: A REPORT FROM THE PROSPECTIVE, MULTI-CENTRE VEDOKIDS STUDY

Zivia Shavit-Brunschwig  1     Oren Ledder  1     Gili Focht  1     Gila Abitbol  1     Darja Urlep  2     Raffi Lev-Tzion  1     Esther Orlanski-Meyer  1     efrat broide  3     Amit Assa     Seamus Hussey     Anat Yerushalmy Feler     Arie Levine     James Markowitz     Marina Aloi     Ronen Stein     Dror Shouval     Christoph Norden     Ron Shaoul     Richard K Russell     Dan Turner    
1 Shaare Zedek Medical Center,Jerusalem,Israel
2 University Children’s Hospital,Ljubljana,Slovenia
3 Shamir

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing